Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Preferred Stock Liabilities: 2020

  • Design Therapeutics' Preferred Stock Liabilities was N/A to $45.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was $45.4 million, marking a year-over-year change of. This contributed to the annual value of $45.4 million for FY2020, which is N/A change from last year.
  • According to the latest figures from Q4 2020, Design Therapeutics' Preferred Stock Liabilities is $45.4 million.
  • Design Therapeutics' 5-year Preferred Stock Liabilities high stood at $45.4 million for Q4 2020, and its period low was $45.4 million during Q4 2020.
  • In the last 1 years, Design Therapeutics' Preferred Stock Liabilities had a median value of $45.4 million in 2020 and averaged $45.4 million.